{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:58:13Z","timestamp":1787317093285,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Electrocardiology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jelectrocard.2017.08.003","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:16:01Z","timestamp":1502237761000},"page":"808-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Electrocardiographic biomarkers to confirm drug's electrophysiological effects used for proarrhythmic risk prediction under CiPA"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9963-1205","authenticated-orcid":false,"given":"Jose","family":"Vicente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meisam","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Johannesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jelectrocard.2017.08.003_bb0005","series-title":"Guideline for Industry E14 Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs","author":"International Council on Harmonisation","year":"2005"},{"issue":"3","key":"10.1016\/j.jelectrocard.2017.08.003_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40264-013-0016-z","article-title":"Dealing with global safety issues: was the response to QT-liability of non-cardiac drugs well coordinated?","volume":"36","author":"Stockbridge","year":"2013","journal-title":"Drug Saf"},{"issue":"10","key":"10.1016\/j.jelectrocard.2017.08.003_bb0015","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jelectrocard.2017.08.003_bb0020","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.RES.64.5.977","article-title":"Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current","volume":"64","author":"January","year":"1989","journal-title":"Circ Res"},{"key":"10.1016\/j.jelectrocard.2017.08.003_bb0025","series-title":"ICH Topic S7B the Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals","author":"International Council on Harmonisation","year":"2005"},{"issue":"3","key":"10.1016\/j.jelectrocard.2017.08.003_bb0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the cardiac safety research consortium","volume":"167","author":"Sager","year":"2014","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.jelectrocard.2017.08.003_bb0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/clpt.2013.238","article-title":"Improving the assessment of heart toxicity for all new drugs through translational regulatory science","volume":"95","author":"Johannesen","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jelectrocard.2017.08.003_bb0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/clpt.2014.155","article-title":"Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of Dofetilide, quinidine, Ranolazine, and verapamil","volume":"96","author":"Johannesen","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jelectrocard.2017.08.003_bb0045","doi-asserted-by":"crossref","first-page":"e001615","DOI":"10.1161\/JAHA.114.001615","article-title":"Comprehensive T wave morphology assessment in a randomized clinical study of Dofetilide, quinidine, Ranolazine, and verapamil","volume":"4","author":"Vicente","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.jelectrocard.2017.08.003_bb0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/cpt.205","article-title":"Late sodium current block for drug-induced long QT syndrome: results from a prospective clinical trial","volume":"99","author":"Johannesen","year":"2016","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.jelectrocard.2017.08.003_bb0055","doi-asserted-by":"crossref","first-page":"e0163619","DOI":"10.1371\/journal.pone.0163619","article-title":"Electrocardiographic biomarkers for detection of drug-induced late sodium current block","volume":"11","author":"Vicente","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jelectrocard.2017.08.003_bb0060","first-page":"677","article-title":"Transformation of the Mason-Likar 12-lead electrocardiogram to the frank vectorcardiogram","volume":"2012","author":"Guldenring","year":"2012","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"10.1016\/j.jelectrocard.2017.08.003_bb0065","series-title":"Comput Cardiol (CinC), 2013","article-title":"Ecglib: library for processing electrocardiograms","author":"Johannesen","year":"2013"},{"key":"10.1016\/j.jelectrocard.2017.08.003_bb0070","series-title":"Comput Cardiol (CinC), 2013","article-title":"ECGlab: user friendly ECG\/VCG analysis tool for research environments","author":"Vicente","year":"2013"},{"issue":"4","key":"10.1016\/j.jelectrocard.2017.08.003_bb0075","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1109\/TBME.2003.821031","article-title":"A wavelet-based ECG delineator: evaluation on standard databases","volume":"51","author":"Mart\u00ednez","year":"2004","journal-title":"IEEE Trans Biomed Eng"},{"issue":"12","key":"10.1016\/j.jelectrocard.2017.08.003_bb0080","doi-asserted-by":"crossref","first-page":"e0166925","DOI":"10.1371\/journal.pone.0166925","article-title":"Automated algorithm for J-Tpeak and Tpeak-tend assessment of drug-induced Proarrhythmia risk","volume":"11","author":"Johannesen","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jelectrocard.2017.08.003_bb0085","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/j.jelectrocard.2006.05.020","article-title":"Understanding proarrhythmic potential in therapeutic drug development: alternate strategies for measuring and tracking repolarization","volume":"39","author":"Lux","year":"2006","journal-title":"J Electrocardiol"},{"issue":"5","key":"10.1016\/j.jelectrocard.2017.08.003_bb0090","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/01.CIR.80.5.1301","article-title":"Electrocardiographic quantitation of ventricular repolarization","volume":"80","author":"Merri","year":"1989","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jelectrocard.2017.08.003_bb0095","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/anec.12227","article-title":"Detection of QTc effects in small studies\u2014implications for replacing the thorough QT study","volume":"20","author":"Ferber","year":"2015","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.jelectrocard.2017.08.003_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/293564","article-title":"The power of phase I studies to detect clinical relevant QTc prolongation: a resampling simulation study","volume":"2015","author":"Ferber","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jelectrocard.2017.08.003_bb0105","author":"Vicente"},{"key":"10.1016\/j.jelectrocard.2017.08.003_bb0110","author":"Vicente"},{"key":"10.1016\/j.jelectrocard.2017.08.003_bb9000","series-title":"An Evaluation of Multiple Algorithms for the Measurement of the Heart Rate Corrected JTpeak Interval","author":"Couderc","year":"2017"}],"container-title":["Journal of Electrocardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073617302431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073617302431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T19:50:32Z","timestamp":1762199432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022073617302431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0022073617302431"],"URL":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2017.08.003","relation":{},"ISSN":["0022-0736"],"issn-type":[{"value":"0022-0736","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrocardiographic biomarkers to confirm drug's electrophysiological effects used for proarrhythmic risk prediction under CiPA","name":"articletitle","label":"Article Title"},{"value":"Journal of Electrocardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2017.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}